I n blood vessels, extracellular nucleotides are involved in a number of physiological functions such as vascular tone, hemostasis, and the inflammatory response because of their direct action on smooth muscle cells, endothelial cells, leukocytes, and platelets. In addition to these short-term effects, nucleotides also are implicated in long-term trophic effects on cell growth, proliferation, and death. 1 Because all of these events have important implications for atherosclerosis, extracellular nucleotides and their receptors could play a role in the progression of this disease. 1, 2 Nucleotides act through specific receptors belonging to the P2 family, which consists of 2 classes of membrane receptor: ligand-gated P2X cation channels and G protein-coupled P2Y receptors. To date, 7 subtypes of mammalian P2X receptors and 8 subtypes of P2Y receptors have been cloned and characterized. 3, 4 However, their role in the development of atherosclerosis has been poorly investigated. The only published study was carried out in collared rabbit carotid arteries and concerned the involvement of the P2Y 2 receptor in the development of intimal hyperplasia, 5 a phenomenon occurring in both atherosclerosis and restenosis after percutaneous transluminal angioplasty.
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The P2Y 1 receptor is widely distributed in many tissues of the body and is present in vascular endothelial cells and circulating blood cells such as leukocytes and platelets. 6, 7 Its role in platelet functions has been extensively investigated. This receptor is necessary for normal platelet aggregation in response to ADP 8, 9 and contributes to interactions between platelets and leukocytes and to the exposure of tissue factor on activated leukocytes. 10, 11 The P2Y 1 receptor plays a key role in arterial thrombosis, as has been demonstrated with P2Y 1 -deficient (P2Y 1 Ϫ/Ϫ ) mice and P2Y 1 antagonists in various models of experimental thrombosis. 9, [12] [13] [14] Hence, this receptor could represent an interesting target for new antiplatelet compounds. 7, 15 The endothelial P2Y 1 receptor contributes, like other P2 receptor subtypes, to nucleotide-induced relaxation 16, 17 and was recently shown also to be involved in human endothelial cell migration. 18 The role of P2Y 1 in leukocytes is less well established.
It has been known for a very long time that blood platelets not only have important functions in hemostasis and thrombus formation but are also involved in the development of atherosclerosis. 19 -21 More recent reports have provided insight into the molecular mechanisms involved in these processes, notably the part played by platelet activation and adhesion to the vessel wall. [22] [23] [24] [25] In addition, the release from platelets of a variety of proinflammatory cytokines, including interleukin-1␤ and RANTES, 26 and exposure of CD40L 27 trigger endothelial inflammation, [27] [28] [29] whereas exposure of P-selectin on the surface of platelets initiates their direct interaction with leukocytes, thereby regulating leukocyte function and overall leading to the recruitment of monocytes to the vessel wall.
Thus, because the P2Y 1 receptor plays an important role in platelet physiology and is present in all cell types and tissues involved in inflammation and atherosclerosis, we wished to explore its potential involvement in the development of atherosclerosis. We therefore crossed apolipoproteindeficient (ApoE Ϫ/Ϫ ) mice with P2Y 1 Ϫ/Ϫ mice to generate P2Y 1 /ApoE double-knockout mice (P2Y 1 Ϫ/Ϫ /ApoE Ϫ/Ϫ ). These animals were maintained on regular chow before collection of the whole aortas and hearts for analysis of the size and composition of atherosclerotic lesions. The latter were found to be reduced in size and to display decreased macrophage infiltration and smooth muscle cell proliferation in P2Y 1 Ϫ/Ϫ / ApoE Ϫ/Ϫ compared with ApoE Ϫ/Ϫ mice. Bone marrow transplantation was performed to determine the relative contributions to the development of atherosclerosis of the P2Y 1 receptors expressed on blood cells and in the rest of the body. Unexpectedly, the results exclude the involvement of platelet and other blood cell P2Y 1 receptors and point to a role of the P2Y 1 receptors of other tissues, most likely the vasculature and/or liver. In view of the known involvement of this receptor in platelet physiology and thrombosis, these findings might be of importance for the development of new antiatherothrombotic strategies.
Methods

Mice, Genotype, and Diet
P2Y 1
Ϫ/Ϫ /ApoE Ϫ/Ϫ mice were generated by mating ApoE Ϫ/Ϫ mice (Charles River, L'Arbresle, France) with P2Y 1 Ϫ/Ϫ mice. 9 After genotyping by polymerase chain reaction analysis, littermates from the F2 generation of this crossbreed were used to establish P2Y 1
ApoE
Ϫ/Ϫ mating, and the resulting progeny was used in our study. All animals were of pure (9-generation backcross) C57BL/6 genetic background and were maintained in the animal facilities of the Etablissement Français du Sang-Alsace. The mice were fed standard mouse chow containing 3% fat (Charles River) from weaning until 17 or 30 weeks of age and then were killed for analysis of atherosclerotic lesions. Ethics approval for animal experiments was received from the French Ministry of Research in accordance with the European Union guidelines.
Plasma Cholesterol and Triglyceride Analysis
At the age of 17 or 30 weeks, blood was drawn from the abdominal aorta of anesthetized mice into citrate (3.15%) anticoagulant. Plasma was isolated by centrifugation at 10 000g for 10 minutes and maintained at 4°C. Concentrations of total cholesterol and triglycerides were determined in total plasma with an enzymatic assay according to the manufacturer's instructions (Cholesterol SL and Triglycerides Mono SL New, Elitech Diagnostics, Sees, France).
Quantification of the Size of the Aortic Sinus Lesions
The heart was perfused with 2 mL of 4% paraformaldehyde and placed in 4% paraformaldehyde overnight. The fixed hearts were washed in PBS, embedded in paraffin, and cross-sectioned. The sections were discarded until reaching the junction of the heart muscle and aorta, where the valve cups become visible. Three consecutive 5-m sections were then collected for each slide, and 20 slides were prepared from each animal. Five sections at 60-m intervals were stained with elastica van Gieson reagent for lesion area measurement or Sirius Red for detection of collagen fibers. The lesion area was measured with image analysis (MetaMorph software, Universal Imaging Corp, Downingtown, Pa) by an operator blinded to genotype. Values reported represent the mean lesion area in 5 sections for each animal.
Immunohistochemical Analysis of the Aortic Sinus Lesions
The macrophage content was analyzed by immunostaining with a rat anti-mouse Mac-3 monoclonal antibody (M3/84, 550292, BD PharMingen, San Diego, Calif) that was revealed with a biotinconjugated anti-rat antibody. Smooth muscle cells were stained with a rabbit polyclonal antibody against human smooth muscle ␣-actin (RB-9010-P, Interchim, Montluçon, France), followed by a biotinconjugated anti-rabbit antibody. Antibodies were revealed with a peroxidase-linked avidin/biotin detection system (Vectastain ABC Kit, Vector Laboratories, Burlingame, Calif), and irrelevant immunoglobulins were used as negative controls. Vascular cell adhesion molecule-1 (VCAM-1) immunostaining was performed on frozen sections with a rat anti-mouse VCAM-1 monoclonal antibody (M/K-2, SouthernBiotech, Birmingham, Ala). Macrophage-, smooth muscle cell-, and VCAM-1-positive regions were quantified in 5 sections at 60-m intervals for each animal by measuring the area staining positive for the respective marker with MetaMorph software. The percentage area of a lesion positive for ␣-actin, Mac-3, or VCAM-1 was determined as the ␣-actin-, Mac-3-, or VCAM-1-positive area of the lesion divided by its total area.
Quantification of the Lesion Size in the Entire Aorta
The aortas of anesthetized mice (17 or 30 weeks old) were excised between the subclavian branch and the iliac bifurcation. The cleaned aortas were cut open longitudinally, fixed in 60% isopropanol for 2 minutes, and stained with Oil Red O. The total and atherosclerotic areas of each aorta were measured with MetaMorph software, and the ratio of the atherosclerotic area to the total area was calculated.
Bone Marrow Transplantation
Bone marrow was harvested by flushing the femurs of the donor mice with Hanks' balanced salt solution under sterile conditions, and the cells were washed and resuspended in that solution. Recipient 5-week-old male mice were sublethally irradiated (12 Gy) with an electron accelerator (Aérial, Illkirch, France). Three hours after irradiation, the recipient mice received 3ϫ10 6 freshly prepared sterile donor bone marrow cells by tail vein injection. During the first 6 weeks after transplantation, the mice were kept in a sterile unit and given sterile food and water, after which they were maintained under the regular conditions of the animal facilities until 30 weeks of age.
Control of Bone Marrow Reconstitution
Because the P2Y 1 receptor is absolutely necessary for platelet aggregation in response to ADP, the successful reconstitution of bone marrowderived cells was verified in each mouse by measuring the aggregation response of washed platelets to ADP. 30 Aggregation was measured at 37°C by a turbidimetric method in a dual-channel Payton aggregometer (Payton Associates, Scarborough, Canada).
Blood cell counts were determined in EDTA-anticoagulated blood with a Scil Vet ABC automatic cell counter (Scil Animal Care Company, Holtzheim, France) set to murine parameters.
Statistical Analyses
Statistical analyses were performed with GraphPad software (Prism 3.0). Data are reported as meanϮSEM and were compared by use of Student's t test to evaluate 2-tailed levels of significance. In the case of bone marrow transplantation experiments, data were compared by use of 1-way ANOVA, followed by a Bonferroni correction posthoc test. Results were considered to be significant at values of PϽ0.05.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results
P2Y 1 Receptor Deficiency Results in a Reduction of Atherosclerosis in ApoE
Analysis of the aortic preparations from 17-week-old animals stained with Oil Red O revealed a statistically significant Figure 1A ). In the aortic sinus, the elastica van Gieson-stained lesion area was 31% less in P2Y Figure 2A ). At this time point, the lesions in the aortic sinus became Figure 2B ).
Effect of P2Y 1 Receptor Deficiency on the Composition of Aortic Sinus Lesions
Immunohistochemical analysis of the aortic sinus was performed to determine the composition of the lesions. At 17 weeks, both ApoE Ϫ/Ϫ and P2Y 1 Ϫ/Ϫ /ApoE Ϫ/Ϫ mice had developed fatty streaks containing mostly macrophages but no smooth muscle cells as evidenced by the absence of ␣-actin staining (data not shown). At the age of 30 weeks, the lesions had progressed to the stage of fibrous plaques in both genotypes. However, Mac-3 staining revealed a marked reduction in the absolute surface area occupied by macrophages in the lesions of P2Y 1 Ϫ/Ϫ /ApoE Ϫ/Ϫ mice compared with those of ApoE Ϫ/Ϫ mice (0.097Ϯ0.008 mm 2 [nϭ15] versus 0.160Ϯ0.014 mm 2 [nϭ16]; **Pϭ0.0019; Figure 3A and 3B). The percentage of total plaque area occupied by macrophages, expressed as the percentage of the cross-sectional area of a lesion, also was significantly reduced in versus 7Ϯ1% [nϭ14]; *Pϭ0.0376; Figure 3B) Figure 3A and 3B), indicating that P2Y 1 receptor deficiency did not modify the collagen content of the lesions.
Analysis of Atherosclerotic Lesions in 30-Week-Old Mice Having Undergone Bone Marrow Transplantation
Bone marrow transplantation was used to determine the relative contributions of the P2Y 1 
/
ApoE
Ϫ/Ϫ bone marrow (ko-ko). Thus, the nomenclature of the chimeras denotes first the P2Y 1 genotype of the hematopoieticderived cells and second that of the rest of the body.
Bone marrow reconstitution was controlled in each recipient mouse by measuring the aggregation of washed platelets in response to ADP. As expected, ADP (10 mol/L) induced the aggregation of platelets derived from wt-wt or wt-ko mice but not of platelets derived from ko-wt or ko-ko mice ( Figure  4) , demonstrating efficient bone marrow transplantation and reconstitution in the recipient animals.
At the age of 30 weeks, the absence of the P2Y 1 receptor in control reconstituted ko-ko mice led to a 27% smaller aortic sinus lesion area than in control reconstituted wt-wt mice (0.38Ϯ0.05 mm 2 [nϭ8] versus 0.52Ϯ0.04 mm 2 [nϭ11]; *PϽ0.05; Figure 5 ), consistent with the results obtained in nontransplanted ApoE Ϫ/Ϫ and P2Y 1 Ϫ/Ϫ /ApoE Ϫ/Ϫ animals (Figure 2A) . Unexpectedly, the absence of the P2Y 1 receptor in blood cells only (ko-wt mice) did not result in any reduction in lesion size compared with wt-wt mice (0.58Ϯ0.03 mm 2 [nϭ7] versus 0.52Ϯ0.04 mm 2 [nϭ11]; PϾ0.05), suggesting that the blood cell P2Y 1 receptors do not contribute to the development of atherosclerotic lesions in mice. In contrast, when the P2Y 1 receptor was absent in all cell types and tissues except blood cells (wt-ko mice), the lesion area was strongly decreased, similar to ko-ko mice (0.43Ϯ0.04 mm 2 [nϭ8] versus 0.38Ϯ0.05 mm 2 [nϭ8]; PϾ0.05; Figure 5 ). Consistent with these results, the difference in atherosclerotic lesion size between wt-ko and ko-wt mice was highly significant (0.43Ϯ0.04 mm 2 in wt-ko mice [nϭ8] versus 0.58Ϯ0.03 mm 2 in ko-wt mice [nϭ8]; *PϽ0.05). Altogether, these data indicate that the contribution of the P2Y 1 receptor to atherosclerosis depends on its expression in tissues other than blood.
Immunohistochemical staining for macrophages revealed a marked reduction in the absolute surface area occupied by macrophages in the lesions of ko-ko mice compared with those of wt-wt mice (0.10Ϯ0.01 mm 2 [nϭ8] versus 0.18Ϯ0.02 mm 2 [nϭ11]; **PϽ0.01), confirming the results obtained in nontransplanted ApoE
animals. Consistent with this, the area staining for macrophages was not significantly different in the lesions of ko-wt mice compared with those of wt-wt mice or in the lesions of wt-ko mice compared with those of ko-ko mice. However, the difference between ko-wt and wt-ko, although measurable, did not reach statistical significance (data not shown).
The smooth muscle cell content also was reduced in the lesions of ko-ko mice compared with those of wt-wt mice, Figure 4 . Platelet aggregation in response to ADP in 30-week-old mice having received bone marrow transplants. Representative platelet aggregation profiles for the 4 groups of mice that received bone marrow transplants. Washed platelets isolated from wt-wt, ko-wt, wt-ko, or ko-ko mice were stimulated with ADP (10 mol/L) in the presence of human fibrinogen (0.25 mg/mL). Platelets in mice having received bone marrow transplants were of donor phenotype, indicating efficient irradiation and successful reconstitution of bone marrow-derived cells.
although the difference did not reach statistical significance, probably because of the smaller number of animals in this experiment (0.019Ϯ0.007 versus 0.038Ϯ0.008 mm 2 [nϭ8]; PϾ0.05).
Body Weight and Plasma Lipid Measurements
Body weights were comparable in all animals used in the experiments. The plasma lipid profile of nontransplanted mice displayed a nonsignificant reduction of Ϸ10% in total cholesterol in P2Y 1 Ϫ/Ϫ /ApoE Ϫ/Ϫ compared with ApoE Ϫ/Ϫ mice. Interestingly, in transplanted mice lacking the P2Y 1 receptor in all tissues except blood, total cholesterol was clearly decreased (15% to 20%) compared with levels in animals expressing the P2Y 1 receptor throughout the body, independently of its presence or absence in blood cells (Tables 1 and  2 ). Although this difference was not statistically significant, probably because the number of animals was too small, it might be relevant to the contribution to atherosclerosis. In contrast, the triglyceride levels were not affected.
Discussion
We report here that the P2Y 1 receptor plays a role in both early and late stages of the development of atherosclerotic lesions. At 17 weeks of age, the lesions formed in the aortic sinus and entire aorta of P2Y 1 Ϫ/Ϫ /ApoE Ϫ/Ϫ mice were smaller than those in ApoE Ϫ/Ϫ mice. At the age of 30 weeks, the aortic root lesions of P2Y 1 Ϫ/Ϫ /ApoE Ϫ/Ϫ mice were still reduced in size and displayed less inflammation, reflected by decreased macrophage infiltration and diminished VCAM-1 immunostaining, compared with the lesions of ApoE Ϫ/Ϫ animals. There also was a reduction in the smooth muscle cell content, whereas the collagen content remained similar between the 2 genotypes.
The P2Y 1 receptor is widely expressed in most cell types and tissues of the body; several, including at least blood cells, the vasculature, and the liver, may be involved in atherosclerosis. Our bone marrow transplantation experiments indicate that blood cell P2Y 1 receptors are not involved in the development of atherosclerosis. This is somewhat surprising because the platelet P2Y 1 receptor is known to play a role in platelet activation, P-selectin exposure, platelet-leukocyte interactions, and expression of tissue factor on monocytes. 10 On the other hand, activated platelets contribute substantially to atherosclerosis. 31 One would therefore have expected the platelet P2Y 1 receptor to play a more important role here. For instance, ticlopidine, an irreversible inhibitor of the second platelet ADP receptor, the P2Y 12 receptor, has been found to inhibit atherosclerotic plaque progression. 32 However, using the analogous P2Y 12 inhibitor clopidogrel, another group did not confirm these results. 33 In any case, it seems unlikely that the platelet P2Y 1 receptor could be responsible for the phenotype of our P2Y 1 -deficient mice. At least 2 other possibilities, not mutually exclusive, might explain the results: the role of the P2Y 1 receptor in the vasculature, in endothelial or smooth muscle cells, and an effect of the P2Y 1 deficiency on metabolic pathways involved in atherosclerosis.
The expression of the P2Y 1 receptor in endothelial cells is well established, whereas its presence in the underlying smooth muscle cells is uncertain. 2 This receptor has been shown to contribute to endothelium-dependent relaxation through nitric oxide and prostacyclin release. 16, 17, 34 However, the function of the P2Y 1 receptor in endothelial cells is largely unknown. Several findings indicate that adenine nucleotides may contribute to an inflammatory state of the endothelium. Thus, these molecules have been reported to increase the expression of E-selectin on primary porcine or bovine aortic endothelial cells 35 ; to upregulate the secretion and expression of interleukin-6, interleukin-8, monocyte chemoattractant protein-1, and intercellular adhesion molecule-1 in dermal endothelial cells 36 ; and to increase the adhesion of leukocytes to endothelial cells. 37, 38 It remains to be determined whether the endothelial P2Y 1 receptor could contribute to these phenomena. This would suggest that P2Y 1 displays a dual role, contributing to the antithrombogenic properties of endothelium by its role on nitric oxide and prostaglandin I 2 release under physiological conditions but also to endothelial cell activation under pathological conditions. Such a dual role has already been reported for another P2Y receptor subtype, P2Y 2 . This receptor contributes to endothelium-dependent relaxation 39 and to the expression of VCAM-1, which mediates the adhesion of monocytes to vascular endothelium. 40 The atherosclerotic lesions of P2Y 1 Ϫ/Ϫ /ApoE Ϫ/Ϫ mice also contained fewer smooth muscle cells than those of ApoE Ϫ/Ϫ mice, indicating that P2Y 1 receptor deficiency might influence the behavior of these cells. This could be an indirect consequence of the reduced monocyte infiltration of the lesions and resultant decreased secretion of chemokines able to attract smooth muscle cells or stimulate their proliferation. 41 On the other hand, the P2Y 1 receptor could be directly involved in the proliferation of smooth muscle cells because extracellular ATP and ADP can act as mitogenics for vascular smooth muscle cells, alone or in synergy with growth factors like platelet-derived growth factor, 42 whereas upregulation of P2Y 1 receptor expression has been observed in vascular smooth muscle cells in culture during the change from a contractile to a synthetic phenotype. 43, 44 Concerning a possible role of the P2Y 1 receptor in metabolic pathways involved in atherosclerosis and notably in lipid metabolism, very few studies have been reported to date. However, one must take into consideration our results for blood cholesterol concentrations, which, although not statistically significant, consistently indicated lower lipidemia in P2Y 1 -deficient animals compared with the other groups. Among the potential hypotheses, a role of the liver P2Y 1 receptor should be investigated in future work.
Our results may have important clinical implications. Indeed, the P2Y 1 receptor plays a key role in platelet activation and in arterial thrombosis, as has been evidenced in P2Y 1 -deficient mice and using selective P2Y 1 antagonists in vitro in platelet function studies and in vivo in animal models of thrombosis. 7 It is thus a potential promising target for new antiplatelet drugs. The demonstration that this receptor also is involved in atherosclerosis obviously adds interest in targeting simultaneously 2 separate aspects of atherothrombosis, ie, platelet activation and development of atherosclerosis. Moreover, because the P2Y 1 receptor plays a more minor role in normal hemostasis compared with the P2Y 12 receptor, one can expect a smaller risk of bleeding with P2Y 1 -targeting 
